Fairfax Media network navigation

  • Home
  • Shares
  • Share details

PRANA BIOTECHNOLOGY LIMITED (PBT)


Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!


General Information
Company Name: Prana Biotechnology Limited
Stock Code: PBT
Website: www.pranabio.com
GICS Sub-Industry: Biotechnology
Market Cap ($M): 86
Equiv. Shares (M): 382

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
 $ 0.225 $ 0.225 $ 0.230 $ 0.225 $ 0.220 576,803 $ 0.005  2.273 %

Company Overview

Business Description:
Prana Biotechnology Ltd. (PBT) is an Australian biotechnology company, which is at an early stage in the development of pharmaceutical products designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses Potential applications for PBT’s MPAC (Metal-Protein Attenuating Compound) technology include Alzheimer’s, Parkinson’s and Huntington’s diseases and brain cancer.

Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2012  A -5.2 -1.8 -- 0.0 0.0 0.0 --
2011  A -6.4 -2.6 -- 0.0 0.0 0.0 --
2010  A -4.9 -2.2 -- 0.0 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F
CSL (CSL) $30,453 M 0.0878 0.3215 0.1438 32.6608 24.7155 21.6080 0.0135 0.0170 0.0192
Mesoblast (MSB) $1,716 M -- -- -- -- -- -- 0.0000 0.0000 0.0000
Prana Biotech (PBT) $84 M -- -- -- -- -- -- 0.0000 -- --
Starpharma (SPL) $237 M -- -- -- -- -- -- 0.0000 0.0000 0.0000
Sirtex Medical (SRX) $606 M 0.4803 0.9043 0.3573 35.9603 18.8837 13.9124 0.0092 0.0176 0.0235

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
PBT -- -- 11.9 -- --
Market 1.13 13.2 0.92 2.50 2.58
Sector 0.65 21.3 2.39 0.55 6.49

Directors
Name Position Start Date
Mr Geoffrey Paul Kempler Chairman,Chief Executive Officer 11 November 1997
Mr Brian Derek Meltzer Non-Executive Director 09 December 1999
Dr George William Mihaly Non-Executive Director 09 December 1999
Mr Peter Marks Non-Executive Director 29 July 2005
Mr Lawrence Gozlan Non-Executive Director 08 August 2011

Management
Name Position
Richard Revelins Chief Financial Officer,Company Secretary
Dianne Angus Chief Operating Officer

Substantial Shareholders
Holding Name
15,409,060 (5.17%) Jagen Nominees Pty Ltd
12,836,682 (4.31%) Atlas Master Fund Ltd
17,055,000 (5.72%) Baywick Pty Ltd

Calendar of Events
Date Event
26 February 2014 Report (Interim)
07 October 2013 Report (Annual)
04 October 2013 Report (Annual)
27 September 2013 Report (Annual)
30 August 2013 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.

Advertisement

Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Leveraged Trading using CFDs

An educational booklet that outlines the different types of Contracts for Difference (CFDs) available in Australia.

More details...

News

Plummeting dollar, budget steal limelight

The Age 18/05/2013 | The sharemarket lost ground this week, slipping 0.6 per cent, but the dollar stole the headlines after dropping like an anvil.

Break-up could breathe new life into News

The Age 18/05/2013 | Analysts say the split into two divisions may lead to a re-rating of the embattled publishing business, writes Colin Kruger.

Wesfarmers shares fall short of their Target

The Age 18/05/2013 | Wesfarmers shares suffered their biggest fall in almost two years after sharply lowering Target's earnings forecast.

China the new competitor in Australia's online sales

The Age 18/05/2013 | As Australia's major retailers increase their online sales channels, pouring millions into their websites, they could face new competition from China's booming e-commerce industry.

China roars along e-tailing superhighway

The Age 18/05/2013 | Mass consumption is coming of age in the internet era, write Richard Cooper and Richard Dobbs.

Delayed return to surplus no worry - what causes it is

The Age 18/05/2013 | Most of those who take a political approach to the budget assume that if it's in deficit, the way you get it back to surplus is to cut government spending or, if you're a really bad person, increase taxes. They forget it's the budget itself that's supposed to do the heavy lifting.

More...

Sponsored Links
Feedback Form